<p>The Abraaj Group (' Abraaj ' or the 'Group'), a leading investor operating in global growth markets, today announced the successful exit through one of its Funds of a partial stake in leading Tunisian pharmaceutical company Unité de fabrication de médicaments ('Unimed' or the 'Company').</p>.... Read more »
Posted on : 12/22/2015